Who are Oxytocin (High dose)'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Oxytocin 4 mIU/mL, Oxytocin bolus or oxytocin infusion, syntocinon nasal spray, Continuous Oxytocin, Carbetocin Short-infusion, Carbetocin infusion.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/oxytocin-high-dose.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Oxytocin (High dose) — Competitive Intelligence Brief

Oxytocin (High dose) (Oxytocin (High dose)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Oxytocin receptor agonist. Area: Obstetrics.

marketed Oxytocin receptor agonist Oxytocin receptor (OXTR) Obstetrics Small molecule Live · refreshed every 30 min

Target snapshot

Oxytocin (High dose) (Oxytocin (High dose)) — The University of Texas Medical Branch, Galveston. High-dose oxytocin binds to oxytocin receptors to enhance uterine contractions and promote labor induction or augmentation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Oxytocin (High dose) TARGET	Oxytocin (High dose)	The University of Texas Medical Branch, Galveston	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)
Oxytocin 4 mIU/mL	Oxytocin 4 mIU/mL	Assistance Publique - Hôpitaux de Paris	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)
Oxytocin bolus or oxytocin infusion	Oxytocin bolus or oxytocin infusion	Stony Brook University	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)
syntocinon nasal spray	syntocinon nasal spray	Rambam Health Care Campus	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)
Continuous Oxytocin	Continuous Oxytocin	Ain Shams Maternity Hospital	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)
Carbetocin Short-infusion	Carbetocin Short-infusion	University Hospital, Basel, Switzerland	marketed	Oxytocin receptor agonist	Oxytocin receptor
Carbetocin infusion	Carbetocin infusion	Ciusss de L'Est de l'Île de Montréal	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Oxytocin receptor agonist class)

Assistance Publique - Hôpitaux de Paris · 2 drugs in this class
Ciusss de L'Est de l'Île de Montréal · 2 drugs in this class
Stony Brook University · 2 drugs in this class
The University of Texas Medical Branch, Galveston · 1 drug in this class
University Hospital, Basel, Switzerland · 1 drug in this class
Ain Shams Maternity Hospital · 1 drug in this class
Weill Medical College of Cornell University · 1 drug in this class
KU Leuven · 1 drug in this class
Rambam Health Care Campus · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Oxytocin (High dose) — Competitive Intelligence Brief. https://druglandscape.com/ci/oxytocin-high-dose. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab